Telemonitoring of Patients With Acute Coronary Syndrome
Key facts
- Who runs it
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department
- Where
- Russia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Suspended
- People taking part
- 950 people, planned
- Started
- 29 Apr 2021
- Ended
- 1 Jun 2025
- Type of study
- Observational, 2 groups
- Record updated
- 10 April 2023
- Why it stopped
- Technical difficulties of the developer
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Signed informed consent
- Age 18 - 80 years old
- Diagnosis:; Acute myocardial infarction (I21.0, I21.1, I21.2, I21.3, I21.4, I21.9); Unstable angina (I20.0) Recurrent myocardial infarction (I22.0, I22.1, I22.8, I22.9)
Who cannot take part
- Participation in other clinical studies to assess the effectiveness of pharmacological drugs
- Severe cognitive dysfunction - dementia leading to maladjustment in everyday life
- Mental illness in the acute stage
- Oncological diseases requiring radiation and chemotherapy during the period of this study, as well as the corresponding stages of T3-4N2-3M1
- Acute coronary syndrome that developed in the hospital after surgery / intervention
- The emergence during observation of the need for surgical (not counting myocardial revascularization) or chemotherapy treatment
- Infection with SARS-CoV-2 with laboratory confirmation during the period of this study
- Lack of technical equipment to connect to remote monitoring programs
- Lack of technical ability to take part in telemonitoring (do not have the skills to work on a smartphone, computer, tablet, there is no appropriate technical means)
- Severe trauma (including craniocerebral) impeding observation according to the study protocol
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
It is planned to enroll 950 patients in an open, prospective, randomized study to assess the impact of telemonitoring on the development of clinical events and improve the quality of life of patients with acute coronary syndrome. The duration of the study is 365 days, of which 180 days are enrollment of patients, 180 days are observation. The study of patients will include the collection of anamnesis, assessment of the clinical status of patients using special questionnaires, data of objective, laboratory and instrumental examinations. The instrumental complex of the examination will include: electrocardiography (ECG), 6-minute walk test (6MWT), Holter ECG monitoring (HMECG), echocardiography, veloergometry (VEM), assessment of the actual nutrition Nutrilogic, autogeneration of an individual diet (Nutrilogic), weekly telemonitoring. Laboratory examination includes: biochemical blood test. The main objectives of the study are to study the effect of telemonitoring on mortality from cardiovascular diseases (CVD), as well as the number of readmissions for cardiovascular pathology in patients with ACS. The secondary endpoints of the study include quality of life as measured by the HeartQol questionnaire and adherence to ambulatory monitoring.
The 2 groups in the trial
- Telemonitoring group
The telemonitoring group will be connected to electronic medical systems, through which medical workers will remotely assess clinical and emotional status, adherence to drug therapy, and carry out nutritional adjustments.
- Control group
Patients with standard administration.
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Influence of Telemonitoring on the Development of Clinical Events and Improving the Quality of Life of Patients With Acute Coronary Syndrome (TeleCor)
- Record updated
- 10 April 2023